[go: up one dir, main page]

NO20080352L - Diclofenacformuleringer og fremgangsmate ved anvendelse - Google Patents

Diclofenacformuleringer og fremgangsmate ved anvendelse

Info

Publication number
NO20080352L
NO20080352L NO20080352A NO20080352A NO20080352L NO 20080352 L NO20080352 L NO 20080352L NO 20080352 A NO20080352 A NO 20080352A NO 20080352 A NO20080352 A NO 20080352A NO 20080352 L NO20080352 L NO 20080352L
Authority
NO
Norway
Prior art keywords
formulations
diclofenac
acute pain
diclofenac formulations
treatment
Prior art date
Application number
NO20080352A
Other languages
English (en)
Other versions
NO342336B1 (no
Inventor
Giorgio Reiner
Alberto Reiner
Andreas Meyer
Original Assignee
Apr Applied Pharma Res Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37396065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080352(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apr Applied Pharma Res Sa filed Critical Apr Applied Pharma Res Sa
Publication of NO20080352L publication Critical patent/NO20080352L/no
Publication of NO342336B1 publication Critical patent/NO342336B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Fremgangsmåter og formuleringer er tilveiebrakt for behandling av migrene og andre akutte smerteepisoder ved bruk av diklofenak, og formuleringer av diklofenak som tilveiebringer både rask og vedvarende lindring fra akutt smerte. Fremgangsmåter og formuleringer er også tilveiebrakt for behandling av symptomer som ofte ledsager migrene og akutt smerte som fotofobi, fonofobi, kvalme og oppkast
NO20080352A 2005-06-17 2008-01-17 Diklofenakformuleringer og deres anvendelse NO342336B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69175705P 2005-06-17 2005-06-17
US69202405P 2005-06-17 2005-06-17
PCT/EP2006/005799 WO2006133954A2 (en) 2005-06-17 2006-06-16 Diclofenac formulations and methods of use

Publications (2)

Publication Number Publication Date
NO20080352L true NO20080352L (no) 2008-03-17
NO342336B1 NO342336B1 (no) 2018-05-07

Family

ID=37396065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080352A NO342336B1 (no) 2005-06-17 2008-01-17 Diklofenakformuleringer og deres anvendelse

Country Status (24)

Country Link
US (7) US7759394B2 (no)
EP (4) EP2402003B1 (no)
KR (1) KR101352130B1 (no)
CN (3) CN112755014A (no)
AR (1) AR057378A1 (no)
AU (1) AU2006257072B2 (no)
BR (1) BRPI0612245A2 (no)
CA (2) CA2632375C (no)
EC (1) ECSP077989A (no)
ES (3) ES2717879T3 (no)
GT (1) GT200600261A (no)
HK (1) HK1213814A1 (no)
JO (1) JO3352B1 (no)
MX (1) MX2007016072A (no)
NO (1) NO342336B1 (no)
NZ (1) NZ564002A (no)
PE (1) PE20070074A1 (no)
PL (1) PL1890680T3 (no)
PT (1) PT1890680T (no)
RU (1) RU2432160C2 (no)
TR (1) TR201706038T4 (no)
TW (1) TW200740470A (no)
WO (1) WO2006133954A2 (no)
ZA (1) ZA200710858B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
US7700125B2 (en) * 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
EP2471522A1 (en) * 2007-05-24 2012-07-04 Novartis AG Oral dosage form providing fast absorption of drug
SG175314A1 (en) * 2009-04-24 2011-11-28 Iceutica Pty Ltd A novel formulation of diclofenac
CN103932988A (zh) 2009-04-24 2014-07-23 伊休蒂卡有限公司 吲哚美辛的新剂型
CA2771831C (en) * 2009-09-25 2018-03-06 Novartis Ag Oral pharmaceutical composition comprising diclofenac
FR2984165B1 (fr) * 2011-12-16 2014-06-27 Pharmeuro Traitement des crises de migraines, notamment d'algies vasculaires de la face
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
US9855234B2 (en) 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
CN106580886A (zh) * 2016-12-05 2017-04-26 北京万全德众医药生物技术有限公司 一种双氯芬酸钾散剂及其制备方法
WO2019030773A1 (en) * 2017-08-10 2019-02-14 Sarudbhava Formulations Private Limited DICLOFENAC COMPOSITIONS WITH LOW DOSE
US11260026B2 (en) 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs
IL298861A (en) 2020-06-10 2023-02-01 Applied Pharma Res Bioavailable sugar-based diclofenac formulations
EP3928766A1 (en) 2020-06-26 2021-12-29 Usso Barnas Pharmaceutical composition and use thereof
US20220241230A1 (en) * 2021-02-03 2022-08-04 Patrin Pharma, Inc. Diclofenac sachet composition
CN115317464B (zh) * 2022-09-01 2023-08-08 苏州弘森药业股份有限公司 一种双氯芬酸钾微胶囊及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
JPS57191962A (en) 1981-05-20 1982-11-25 Hitachi Ltd Fuel cell
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
CH673395A5 (no) * 1987-01-30 1990-03-15 Ciba Geigy Ag
US5211957A (en) * 1988-03-25 1993-05-18 Ciba-Geigy Corporation Solid rapidly disintegrating dosage form
IT1226549B (it) 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
GB8824392D0 (en) 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
GB8920693D0 (en) 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
DE59105562D1 (de) 1990-06-28 1995-06-29 Ciba Geigy Ag Alpha-Carbonylphenylacetonitrilderivate als Stabilisatoren für organische Materialien.
EP0466650A2 (en) 1990-07-11 1992-01-15 Warner-Lambert Company Improvements in non-steroidal anti-inflammatory therapy
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
ES2173096T3 (es) * 1992-08-05 2002-10-16 Faulding F H & Co Ltd Composicion farmaceutica peletizada.
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
DE9422239U1 (de) 1993-09-07 1999-05-06 Gergely, Gerhard, Dr., Wien Modifizierte Kristalle einer festen, eßbaren, organischen Säure
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
WO1995032737A1 (en) 1994-05-27 1995-12-07 Farmarc Nederland Bv Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
IT1283029B1 (it) * 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
DE19538555A1 (de) 1995-10-17 1997-04-24 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
US7687542B2 (en) * 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
US20060013896A1 (en) * 1996-05-17 2006-01-19 Giorgio Reiner Methods of treating acute pain using diclofenac
US5854279A (en) * 1996-06-04 1998-12-29 Eisai Co., Ltd Therapeutic agent for dermatosis
US5914129A (en) 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6713089B1 (en) 1998-09-10 2004-03-30 Nycomed Danmark A/S Quick release pharmaceutical compositions of drug substances
ATE242626T1 (de) * 2001-11-20 2003-06-15 Applied Pharma Res Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält
KR20060015587A (ko) 2003-05-08 2006-02-17 넥타 쎄라퓨틱스 유케이 리미티드 미립물
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
US7700125B2 (en) * 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
US7939561B2 (en) * 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens

Also Published As

Publication number Publication date
NZ564002A (en) 2011-03-31
EP2705837B1 (en) 2019-02-20
EP1890680A2 (en) 2008-02-27
MX2007016072A (es) 2008-03-10
EP2402003A2 (en) 2012-01-04
JO3352B1 (ar) 2019-03-13
KR20080024202A (ko) 2008-03-17
ZA200710858B (en) 2008-12-31
ES2912897T3 (es) 2022-05-30
AU2006257072B2 (en) 2012-08-16
PT1890680T (pt) 2017-05-05
TR201706038T4 (tr) 2019-02-21
EP3103441A1 (en) 2016-12-14
RU2432160C2 (ru) 2011-10-27
US20070015831A1 (en) 2007-01-18
US20150064258A1 (en) 2015-03-05
GT200600261A (es) 2007-02-05
US9827197B2 (en) 2017-11-28
CA2932603C (en) 2017-08-08
EP3103441B1 (en) 2022-03-16
TW200740470A (en) 2007-11-01
CA2932603A1 (en) 2006-12-21
ES2717879T3 (es) 2019-06-26
RU2008101784A (ru) 2009-07-27
EP1890680B1 (en) 2017-03-08
PE20070074A1 (es) 2007-02-08
US20100204330A1 (en) 2010-08-12
EP2705837A1 (en) 2014-03-12
US20200323776A1 (en) 2020-10-15
KR101352130B1 (ko) 2014-02-06
WO2006133954A3 (en) 2007-07-26
US7759394B2 (en) 2010-07-20
BRPI0612245A2 (pt) 2010-10-26
CN104856959A (zh) 2015-08-26
ECSP077989A (es) 2008-03-26
EP2402003A3 (en) 2012-05-09
CN101272768A (zh) 2008-09-24
AR057378A1 (es) 2007-11-28
US8097651B2 (en) 2012-01-17
EP2402003B1 (en) 2020-05-06
US20090197961A1 (en) 2009-08-06
PL1890680T3 (pl) 2017-08-31
CN112755014A (zh) 2021-05-07
US20170319484A1 (en) 2017-11-09
CA2632375A1 (en) 2006-12-21
US20130245122A1 (en) 2013-09-19
HK1213814A1 (zh) 2016-07-15
US8927604B2 (en) 2015-01-06
WO2006133954A2 (en) 2006-12-21
ES2641889T3 (es) 2017-11-14
NO342336B1 (no) 2018-05-07
CA2632375C (en) 2016-08-16
AU2006257072A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
NO20080352L (no) Diclofenacformuleringer og fremgangsmate ved anvendelse
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
NO20091020L (no) Indol forbindelser
NO20080141L (no) Indanderivater som modulatorer av ionekanaler
CL2009001993A1 (es) Compuestos derivados de 6-oxo-4-fenilamino-1,6-dihidropiridina-3-amida, inhibidores de mek; proceso de preparacion de estos, utiles en el tratamiento de un trastorno hiperproliferativo o una condicion inflamatoria. (divisional de la solicitud cl 1168-06)
MX2009011002A (es) Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
MX2009009292A (es) Compuestos activos en ppar.
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
NO20081042L (no) PPAR aktive forbindelser
EA201070127A1 (ru) Способы лечения легочной гипертензии, родственных заболеваний и нарушений и композиции для их осуществления
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
WO2010118063A3 (en) Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
MX2010006241A (es) Derivados de aminotriazol como agonistas de alx.
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
NO20085099L (no) Puritonderivativer som HM74A agonister
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
TW200716088A (en) Formulations and methods for treating amyloidosis
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.
MY159244A (en) Method of reducing intraocular pressure in humans